Use of experimental vaccines is ethically permissible during public health emergencies | ||
| dc.conicet.fuente | Crossref | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Saavedra 15. Instituto de Investigaciones Sociales de América Latina. - Facultad Latinoamericana de Ciencias Sociales. Instituto de Investigaciones Sociales de América Latina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.produccionid | 12132336 | |
| dc.contributor.author | Mastroleo, Ignacio Damian | |
| dc.date.accessioned | 2025-05-30T12:30:07Z | |
| dc.date.available | 2025-05-30T12:30:07Z | |
| dc.date.issued | 2025-01 | |
| dc.date.updated | 2025-05-15T14:26:50Z | |
| dc.description.abstract | Smith and Emanuel's paper is timely and important [1]. Here I want to revisit and extend their analysis of the first bad argument regarding the use of experimental vaccines for COVID-19. My aims are two-fold. First, to show that the force of the Nuremberg argument stating that vaccination mandates violate the Nuremberg Code because COVID-19 vaccines are ‘experimental’ is merely emotional and rests on a false analogy. Second, to reclaim a neutral use of the term experimental –referring to a “lack of sufficient evidence for regular use in healthcare” [2]– to defend that vaccination with experimental vaccines (mandatory or not) during a public health emergency is permissible when it meets the criteria of sufficient evidence for use during a public health emergency together with other appropriate regulatory and ethical criteria. | es |
| dc.description.fil | Fil: Mastroleo, Ignacio Damian. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Saavedra 15. Instituto de Investigaciones Sociales de América Latina. - Facultad Latinoamericana de Ciencias Sociales. Instituto de Investigaciones Sociales de América Latina; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Mastroleo, Ignacio Damian; Use of experimental vaccines is ethically permissible during public health emergencies; Elsevier; Vaccine; 44; 125919; 1-2025; 1-2 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0264-410X | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/263027 | |
| dc.journal.ciudad | Amsterdam | es |
| dc.journal.number | 125919 | es |
| dc.journal.pagination | 1-2 | es |
| dc.journal.pais | Países Bajos | es |
| dc.journal.title | Vaccine | es |
| dc.journal.volume | 44 | es |
| dc.language.iso | eng | es |
| dc.publisher | Elsevier | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/abs/pii/S0264410X24005048 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.vaccine.2024.04.065 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | Emergency use authorization | es |
| dc.subject | Experimental vaccines | es |
| dc.subject | Nuremberg argument | es |
| dc.subject | COVID-19 | es |
| dc.subject.classification | Ética relacionada con Biotecnología Médica | es |
| dc.subject.classification | Biotecnología de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Use of experimental vaccines is ethically permissible during public health emergencies | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.b5a3f6d2-5480-437f-b4fc-be91f41fc710_B.pdf
- Tamaño:
- 252.75 KB
- Formato:
- Adobe Portable Document Format